The World Health Organisation (WHO) has said that additional clarifications from manufacturer are needed to conduct a final Emergency Use Listing (EUL) risk-benefit assessment for global use of India-made COVAXIN.
“Technical Advisory Group (TAG) for Emergency Use Listing has decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine,” the WHO said.
MCA to approach Rohit Sharma over his availability for Ranji Trophy as the Indian skipper…
Actor Saif Ali Khan, stabbed by an intruder at home, is undergoing treatment in Mumbai.…
The landmark 3-phase Gaza deal brings hope for peace, featuring a ceasefire, hostage exchanges, and…
Aghori sadhus follow mysterious and shocking rituals, including consuming remains from cremation grounds. Their unique…
Bengaluru introduces "Miss and Mrs," India’s first women-only club, providing a safe, vibrant space with…
An AI-created video featuring Elon Musk, Lionel Messi, and global icons taking a dip at…